*Product images are for illustrative purposes only and may differ from the actual product.
Description
For the Use of Respiratory Physicians, Dermatologists and Immunologists with Extensive Experience in Treatment of Bronchial Asthma and Chronic Idiopathic Urticaria.
Emzumab (omalizumab) is indicated for adult patients with moderate to severe persistent asthma who have a positive skin test or in vitro reactivity to a perennial aeroallergen and whose symptoms are inadequately controlled with inhaled corticosteroids.